152 related articles for article (PubMed ID: 36246406)
1. A Macrophage Differentiation-Mediated Gene: DDX20 as a Molecular Biomarker Encompassing the Tumor Microenvironment, Disease Staging, and Prognoses in Hepatocellular Carcinoma.
Yang Y; Yang M; Pang H; Qiu Y; Sun T; Wang T; Shen S; Wang W
Oxid Med Cell Longev; 2022; 2022():9971776. PubMed ID: 36246406
[TBL] [Abstract][Full Text] [Related]
2. A miRNA machinery component DDX20 controls NF-κB via microRNA-140 function.
Takata A; Otsuka M; Yoshikawa T; Kishikawa T; Kudo Y; Goto T; Yoshida H; Koike K
Biochem Biophys Res Commun; 2012 Apr; 420(3):564-9. PubMed ID: 22445758
[TBL] [Abstract][Full Text] [Related]
3. High expression of DDX20 enhances the proliferation and metastatic potential of prostate cancer cells through the NF-κB pathway.
Chen W; Zhou P; Li X
Int J Mol Med; 2016 Jun; 37(6):1551-7. PubMed ID: 27121695
[TBL] [Abstract][Full Text] [Related]
4. CircRNA hsa_circ_0110102 inhibited macrophage activation and hepatocellular carcinoma progression via miR-580-5p/PPARα/CCL2 pathway.
Wang X; Sheng W; Xu T; Xu J; Gao R; Zhang Z
Aging (Albany NY); 2021 Apr; 13(8):11969-11987. PubMed ID: 33891564
[TBL] [Abstract][Full Text] [Related]
5. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
6. Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma.
Ye Y; Guo J; Xiao P; Ning J; Zhang R; Liu P; Yu W; Xu L; Zhao Y; Yu J
Cancer Lett; 2020 Jan; 469():310-322. PubMed ID: 31705929
[TBL] [Abstract][Full Text] [Related]
7. Death-associated protein kinase 1 suppresses hepatocellular carcinoma cell migration and invasion by upregulation of DEAD-box helicase 20.
Huang Y; Wang C; Li K; Ye Y; Shen A; Guo L; Chen P; Meng C; Wang Q; Yang X; Huang Z; Xing X; Lin Y; Liu X; Peng J; Lin Y
Cancer Sci; 2020 Aug; 111(8):2803-2813. PubMed ID: 32449268
[TBL] [Abstract][Full Text] [Related]
8. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
[TBL] [Abstract][Full Text] [Related]
9. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of miR-1266-5p serves as a prognostic biomarker of hepatocellular carcinoma and facilitates tumor cell proliferation, migration and invasion.
Su Y; Xie R; Xu Q
Acta Biochim Pol; 2021 May; 68(2):293-300. PubMed ID: 34006084
[TBL] [Abstract][Full Text] [Related]
11. Human bone mesenchymal stem cells-derived exosomal miRNA-361-5p alleviates osteoarthritis by downregulating DDX20 and inactivating the NF-κB signaling pathway.
Tao Y; Zhou J; Wang Z; Tao H; Bai J; Ge G; Li W; Zhang W; Hao Y; Yang X; Geng D
Bioorg Chem; 2021 Aug; 113():104978. PubMed ID: 34052737
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
Wang K; Liang Q; Wei L; Zhang W; Zhu P
Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.
Zhao H; Xie Z; Tang G; Wei S; Chen G
J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-139-5p negatively regulates NME1 expression in hepatocellular carcinoma cells.
Yang J; Li Z; Pang Y; Zhou T; Sun J; Cheng XY; Zheng WV
Adv Clin Exp Med; 2022 Jun; 31(6):655-670. PubMed ID: 35438846
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.
Wu S; Liu S; Cao Y; Chao G; Wang P; Pan H
Aging (Albany NY); 2022 Mar; 14(5):2304-2319. PubMed ID: 35278064
[TBL] [Abstract][Full Text] [Related]
17. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
19. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
Zhao J; Xu T; Wang F; Cai W; Chen L
Biomed Pharmacother; 2017 Jun; 90():744-751. PubMed ID: 28419971
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
